Table 2.
miR-21 | miR-27b | miR-181b | |||
---|---|---|---|---|---|
Controls | CT | 17.201 | 20.515 | 29.975 | |
ΔCT | −4.283 | −0.969 | 8.373 | ||
OPMD | No dysplasia | CT | 15.619 | 18.741 | 28.904 |
ΔCT | −3.756 | −0.633 | 9.530 | ||
ΔΔCT | 0.527 | 0.336 | 1.157 | ||
Log2(2-(ΔΔCT)) | −0.527 | −0.336 | −1.157 | ||
p-value (2-tailed) | 0.999 | 0.950 | 0.971 | ||
Dysplasia | CT | 23.677 | 28.726 | 27.479 | |
ΔCT | −1.491 | 3.558 | 3.234 | ||
ΔΔCT | 2.792 | 4.527 | −5.139 | ||
Log2(2-(ΔΔCT)) | −2.792 | −4.52 | 5.139 | ||
p-value (2-tailed) | 0.129 | 0.042 | 0.006 | ||
LG-dysplasia | CT | 22.502 | 27.465 | 27.612 | |
ΔCT | −1.494 | 3.469 | 4.624 | ||
ΔΔCT | 2.789 | 4.438 | −3.749 | ||
Log2(2-(ΔΔCT)) | −2.789 | −4.44 | 3.749 | ||
p-value (2-tailed) | 0.573 | 0.405 | 0.093 | ||
HG-dysplasia | CT | 24.500 | 29.609 | 27.390 | |
ΔCT | −1.489 | 3.621 | 2.261 | ||
ΔΔCT | 2.795 | 4.590 | −6.112 | ||
Log2(2-(ΔΔCT)) | −2.795 | −4.590 | 6.112 | ||
p-value (2-tailed) | 0.477 | 0.373 | 0.006 | ||
OSCC | CT | 17.212 | 19.708 | 31,987 | |
ΔCT | −4.079 | −1.220 | 10,626 | ||
ΔΔCT | 0.204 | −0.251 | 2253 | ||
Log2(2-(ΔΔCT)) | −0.204 | 0.251 | −2253 | ||
p-value (2-tailed) | 0.945 | 0.997 | 0.509 |